Renaissance Technologies (RenTech)'s USNA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.02 M shares of USANA Health Sciences, Inc. (USNA) worth $17.78 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in USNA, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2014, adding 194,966 shares. Largest reduction occurred in Q4 2018, reducing 217,492 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s USANA Health Sciences (USNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly USANA Health Sciences (USNA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -129,693 | Reduce 11.30% | 1.02 M | $17.47 |
| Q4 2025 | +21,793 | Add 1.94% | 1.15 M | $19.63 |
| Q3 2025 | -29,300 | Reduce 2.54% | 1.13 M | $27.55 |
| Q2 2025 | +69,566 | Add 6.41% | 1.15 M | $30.53 |
| Q1 2025 | -5,600 | Reduce 0.51% | 1.09 M | $26.97 |
| Q4 2024 | -58,400 | Reduce 5.08% | 1.09 M | $35.89 |
| Q3 2024 | -29,899 | Reduce 2.54% | 1.15 M | $37.92 |
| Q2 2024 | -43,200 | Reduce 3.53% | 1.18 M | $45.24 |
| Q1 2024 | +23,666 | Add 1.97% | 1.22 M | $48.50 |
| Q4 2023 | -9,300 | Reduce 0.77% | 1.2 M | $53.60 |
| Q3 2023 | -1,300 | Reduce 0.11% | 1.21 M | $58.61 |
| Q2 2023 | -2,500 | Reduce 0.21% | 1.21 M | $0.06 |
| Q1 2023 | -13,200 | Reduce 1.08% | 1.21 M | $0.06 |
| Q4 2022 | -82,800 | Reduce 6.33% | 1.22 M | $0.05 |
| Q3 2022 | -124,000 | Reduce 8.66% | 1.31 M | $56.05 |
| Q2 2022 | +7,534 | Add 0.53% | 1.43 M | $72.36 |
| Q1 2022 | -31,834 | Reduce 2.19% | 1.42 M | $79.45 |
| Q4 2021 | -62,603 | Reduce 4.12% | 1.46 M | $101.20 |
| Q3 2021 | -26,700 | Reduce 1.73% | 1.52 M | $92.20 |
| Q2 2021 | -22,600 | Reduce 1.44% | 1.55 M | $102.43 |
| Q1 2021 | -154,966 | Reduce 8.99% | 1.57 M | $97.60 |
| Q4 2020 | -71,900 | Reduce 4.01% | 1.72 M | $77.10 |
| Q3 2020 | +26,200 | Add 1.48% | 1.79 M | $73.65 |
| Q2 2020 | +186,966 | Add 11.82% | 1.77 M | $73.43 |
| Q1 2020 | -44,200 | Reduce 2.72% | 1.58 M | $57.76 |
| Q4 2019 | -33,200 | Reduce 2.00% | 1.63 M | $78.55 |
| Q3 2019 | -129,300 | Reduce 7.23% | 1.66 M | $68.39 |
| Q2 2019 | -118,966 | Reduce 6.24% | 1.79 M | $79.43 |
| Q1 2019 | +25,692 | Add 1.37% | 1.91 M | $83.87 |
| Q4 2018 | -217,492 | Reduce 10.36% | 1.88 M | $117.73 |
| Q3 2018 | -6,300 | Reduce 0.30% | 2.1 M | $120.55 |
| Q2 2018 | +144,000 | Add 7.34% | 2.11 M | $115.30 |
| Q1 2018 | +30,500 | Add 1.58% | 1.96 M | $85.90 |
| Q4 2017 | +12,700 | Add 0.66% | 1.93 M | $74.05 |
| Q3 2017 | -30,000 | Reduce 1.54% | 1.92 M | $57.70 |
| Q2 2017 | +186,600 | Add 10.59% | 1.95 M | $64.10 |
| Q1 2017 | +128,766 | Add 7.89% | 1.76 M | $57.60 |
| Q4 2016 | +33,734 | Add 2.11% | 1.63 M | $61.20 |
| Q3 2016 | +29,400 | Add 1.87% | 1.6 M | $69.17 |
| Q2 2016 | +115,366 | Add 7.93% | 1.57 M | $55.72 |
| Q1 2016 | -93,966 | Reduce 6.07% | 1.45 M | $60.71 |
| Q4 2015 | -125,400 | Reduce 7.49% | 1.55 M | $63.88 |
| Q3 2015 | +144,200 | Add 9.43% | 1.67 M | $67.01 |
| Q2 2015 | -113,600 | Reduce 6.91% | 1.53 M | $68.33 |
| Q1 2015 | +47,400 | Add 2.97% | 1.64 M | $55.56 |
| Q4 2014 | +194,966 | Add 13.92% | 1.6 M | $51.30 |
| Q3 2014 | +49,000 | Add 3.62% | 1.4 M | $36.83 |
| Q2 2014 | +42,834 | Add 3.27% | 1.35 M | $39.07 |
| Q1 2014 | +146,566 | Add 12.61% | 1.31 M | $37.67 |
| Q4 2013 | +142,200 | Add 13.94% | 1.16 M | $37.79 |
| Q3 2013 | +160,600 | Add 18.68% | 1.02 M | $43.40 |
| Q2 2013 | +859,600 | Add 0.00% | 859,600 | $36.19 |
Renaissance Technologies (RenTech)'s USANA Health Sciences Investment FAQs
Renaissance Technologies (RenTech) first purchased USANA Health Sciences, Inc. (USNA) in Q2 2013, acquiring 859,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held USANA Health Sciences, Inc. (USNA) for 52 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to USANA Health Sciences, Inc. (USNA) was in Q2 2013, adding 859,600 shares worth $31.11 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,017,630 shares of USANA Health Sciences, Inc. (USNA), valued at approximately $17.78 M.
As of the Q1 2026 filing, USANA Health Sciences, Inc. (USNA) represents approximately 0.03% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in USANA Health Sciences, Inc. (USNA) was 2,105,466 shares, as reported at the end of Q2 2018.